MLI Webinar: Exploring Innovation in Canadian Health Care
MLI Webinar: Exploring Innovation in Canadian Health Care
How a trans activist group undermined medical science: Aaron Wudrick and Mia Hughes for Inside Policy Talks

The craving is just not there: How Ozempic is affecting snacking culture – National [Video]

Categories
Nova Scotia News

Medications used for weight loss such as Ozempic may be stirring up the food industry, with a recent report revealing that Canadians on certain drugs are tightening their belts on restaurant outings, snack indulgences and drinking alcohol.

A report published Tuesday by Dalhousie University’s Agri-Food Analytics Lab in Halifax estimates that between 900,000 and 1.4 million Canadians use GLP-1 receptor agonists. These are a group of drugs used to treat Type 2 diabetes and are often used to combat obesity. They trigger insulin release, reduce glucose production in your liver and make you feel full. Examples of these drugs include Ozempic, Wegovy and Saxenda.

Over the past few years, there has been a huge boom in the popularity of Novo Nordisk’s Ozempic, a Type 2 diabetes drug that is also known for its off-label use for weight loss. The demand for Ozempic and its sister drug Wegovy is so high that it has also led to shortages in …

Facing the Sino-Russian axis / Double Trouble: Balkan Devlen and Jonathan Berkshire Miller
Facing the Sino-Russian axis / Double Trouble: Balkan Devlen and Jonathan Berkshire Miller
Abraham Accords provide a solution for rebuilding Gaza post-Hamas: Raheel Raza and Mohammed Rizwan in the National Post